These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 31053466)
1. Physician-pharmacist collaboration on chronic non-cancer pain management during the opioid crisis: A qualitative interview study. Kang I; Urick B; Vohra R; Ives TJ Res Social Adm Pharm; 2019 Aug; 15(8):1027-1031. PubMed ID: 31053466 [TBL] [Abstract][Full Text] [Related]
2. Physicians' perspectives of pharmacist-physician collaboration in the United Arab Emirates: Findings from an exploratory study. Hasan S; Stewart K; Chapman CB; Kong DCM J Interprof Care; 2018 Sep; 32(5):566-574. PubMed ID: 29589781 [TBL] [Abstract][Full Text] [Related]
3. Exploring successful community pharmacist-physician collaborative working relationships using mixed methods. Snyder ME; Zillich AJ; Primack BA; Rice KR; Somma McGivney MA; Pringle JL; Smith RB Res Social Adm Pharm; 2010 Dec; 6(4):307-23. PubMed ID: 21111388 [TBL] [Abstract][Full Text] [Related]
4. Pharmacist, physician, and patient opinions of pharmacist-treated minor ailments and conditions. McKeirnan KC; Garrelts MacLean L J Am Pharm Assoc (2003); 2018; 58(6):599-607. PubMed ID: 30266565 [TBL] [Abstract][Full Text] [Related]
5. Expanding the role of clinical pharmacists on interdisciplinary primary care teams for chronic pain and opioid management. Giannitrapani KF; Glassman PA; Vang D; McKelvey JC; Thomas Day R; Dobscha SK; Lorenz KA BMC Fam Pract; 2018 Jul; 19(1):107. PubMed ID: 29970008 [TBL] [Abstract][Full Text] [Related]
6. Family physicians' perceptions of pharmacists prescribing in Alberta. Faruquee CF; Khera AS; Guirguis LM J Interprof Care; 2020; 34(1):87-96. PubMed ID: 31043099 [TBL] [Abstract][Full Text] [Related]
7. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States. Gordon C; Unni E; Montuoro J; Ogborn DB Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803 [TBL] [Abstract][Full Text] [Related]
8. Exploring pharmacy service users' support for and willingness to use community pharmacist prescribing services. Famiyeh IM; MacKeigan L; Thompson A; Kuluski K; McCarthy LM Res Social Adm Pharm; 2019 May; 15(5):575-583. PubMed ID: 30100199 [TBL] [Abstract][Full Text] [Related]
9. Communication Experiences of DATA-Waivered Physicians with Community Pharmacists: A Qualitative Study. Ventricelli DJ; Mathis SM; Foster KN; Pack RP; Tudiver F; Hagemeier NE Subst Use Misuse; 2020; 55(3):349-357. PubMed ID: 31591924 [No Abstract] [Full Text] [Related]
10. Identification of critical factors for forming collaborative relationships between physicians and pharmacists. Turner KM; Nelson CA; Pestka DL; Sorensen TD Am J Health Syst Pharm; 2019 Aug; 76(16):1238-1247. PubMed ID: 31369113 [TBL] [Abstract][Full Text] [Related]
11. Physician-reported factors that encourage collaboration with community pharmacists. Pezzino NC; Marciniak MW; Smith MG; Ferreri SP J Am Pharm Assoc (2003); 2017; 57(3S):S279-S283.e2. PubMed ID: 28411013 [TBL] [Abstract][Full Text] [Related]
12. A narrative review of risk mitigation strategies in the management of opioids for chronic pain and palliative care in older adults: interprofessional collaboration with the pharmacist. Mohammad I; Garwood CL; Binns-Emerick L Ann Palliat Med; 2024 Jul; 13(4):901-913. PubMed ID: 38735692 [TBL] [Abstract][Full Text] [Related]
13. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study. Wibowo Y; Sunderland B; Hughes J Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327 [TBL] [Abstract][Full Text] [Related]
14. Communication between pharmacists and primary care physicians in the midst of a U.S. opioid crisis. Curran GM; Freeman PR; Martin BC; Teeter BS; Drummond KL; Bradley K; Thannisch MM; Mosley CL; Schoenberg N; Edlund M Res Social Adm Pharm; 2019 Aug; 15(8):974-985. PubMed ID: 30170901 [TBL] [Abstract][Full Text] [Related]
15. How physician and community pharmacist perceptions of the community pharmacist role in Australian primary care influence the quality of collaborative chronic disease management. Rieck A; Pettigrew S Qual Prim Care; 2013; 21(2):105-11. PubMed ID: 23735691 [TBL] [Abstract][Full Text] [Related]
16. Factors influencing the degree of physician-pharmacist collaboration within Iraqi public healthcare settings. Al-Jumaili AA; Al-Rekabi MD; Doucette W; Hussein AH; Abbas HK; Hussein FH Int J Pharm Pract; 2017 Dec; 25(6):411-417. PubMed ID: 28181318 [TBL] [Abstract][Full Text] [Related]
17. Challenges faced with opioid prescriptions in the community setting - Australian pharmacists' perspectives. Makdessi CJ; Day C; Chaar BB Res Social Adm Pharm; 2019 Aug; 15(8):966-973. PubMed ID: 30819418 [TBL] [Abstract][Full Text] [Related]
18. Physician-pharmacist collaborative care in dyslipidemia management: the perception of clinicians and patients. Lalonde L; Hudon E; Goudreau J; Bélanger D; Villeneuve J; Perreault S; Blais L; Lamarre D Res Social Adm Pharm; 2011 Sep; 7(3):233-45. PubMed ID: 21272548 [TBL] [Abstract][Full Text] [Related]
19. Interprofessional prescription opioid abuse communication among prescribers and pharmacists: A qualitative analysis. Hagemeier NE; Tudiver F; Brewster S; Hagy EJ; Ratliff B; Hagaman A; Pack RP Subst Abus; 2018 Jan; 39(1):89-94. PubMed ID: 28799863 [TBL] [Abstract][Full Text] [Related]